PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 35580565-3 2022 Here, we present the case of a 69-year-old woman with therapy-related nucleophosmin-1 (NPM1) and FLT3-internal tandem duplication (FLT3-ITD) positive acute myeloid leukemia treated with induction and consolidation with CPX-351 (liposomal daunorubicin plus cytarabine) followed by off-label azacitidine maintenance who obtained a complete remission (CR) with persistent measurable residual disease. Daunorubicin 238-250 fms related receptor tyrosine kinase 3 Homo sapiens 97-101 35580565-3 2022 Here, we present the case of a 69-year-old woman with therapy-related nucleophosmin-1 (NPM1) and FLT3-internal tandem duplication (FLT3-ITD) positive acute myeloid leukemia treated with induction and consolidation with CPX-351 (liposomal daunorubicin plus cytarabine) followed by off-label azacitidine maintenance who obtained a complete remission (CR) with persistent measurable residual disease. Daunorubicin 238-250 fms related receptor tyrosine kinase 3 Homo sapiens 131-135